CY1112316T1 - Πυριδινο μεθυλενο αζολιδινονες και η χρηση αυτων ως αναστολεις φωσφοϊνοσιτιδιων - Google Patents
Πυριδινο μεθυλενο αζολιδινονες και η χρηση αυτων ως αναστολεις φωσφοϊνοσιτιδιωνInfo
- Publication number
- CY1112316T1 CY1112316T1 CY20121100119T CY121100119T CY1112316T1 CY 1112316 T1 CY1112316 T1 CY 1112316T1 CY 20121100119 T CY20121100119 T CY 20121100119T CY 121100119 T CY121100119 T CY 121100119T CY 1112316 T1 CY1112316 T1 CY 1112316T1
- Authority
- CY
- Cyprus
- Prior art keywords
- phosphosphysite
- inhibitors
- diseases
- azolidinones
- methylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με παράγωγα συγχωνευμένων πυριδινο μεθυλενο αζολιδινονών του τύπου (Ι) ειδικότερα για την αγωγή και/ή προφύλαξη αυτοάνοσων διαταραχών και/ή φλεγμονωδών παθήσεων, καρδιαγγειακών παθήσεων, νευροεκφυλιστικών παθήσεων, βακτηριακών ή ιικών μολύνσεων, νεφρικών παθήσεων, συσσωμάτωσης αιμοπεταλίων, καρκίνου, μεταμόσχευσης, απόρριψης μοσχεύματος ή κακώσεων πνεύμονα.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60737404P | 2004-09-03 | 2004-09-03 | |
EP04104259 | 2004-09-03 | ||
EP05797231A EP1786812B1 (en) | 2004-09-03 | 2005-09-02 | Pyridine methylene azolidinones and their use as phosphoinositide inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112316T1 true CY1112316T1 (el) | 2015-12-09 |
Family
ID=35457295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100119T CY1112316T1 (el) | 2004-09-03 | 2012-02-02 | Πυριδινο μεθυλενο αζολιδινονες και η χρηση αυτων ως αναστολεις φωσφοϊνοσιτιδιων |
Country Status (20)
Country | Link |
---|---|
US (2) | US7842698B2 (el) |
EP (1) | EP1786812B1 (el) |
JP (1) | JP5209311B2 (el) |
KR (1) | KR101229647B1 (el) |
CN (1) | CN101052640B (el) |
AT (1) | ATE532783T1 (el) |
AU (1) | AU2005279156B2 (el) |
BR (1) | BRPI0515627A (el) |
CA (1) | CA2576765C (el) |
CY (1) | CY1112316T1 (el) |
EA (1) | EA012178B1 (el) |
HK (1) | HK1106773A1 (el) |
HR (1) | HRP20110834T1 (el) |
IL (1) | IL181415A (el) |
MX (1) | MX2007002604A (el) |
NO (1) | NO20071605L (el) |
PL (1) | PL1786812T3 (el) |
SI (1) | SI1786812T1 (el) |
WO (1) | WO2006024666A1 (el) |
ZA (1) | ZA200701666B (el) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011686A1 (en) | 2003-07-28 | 2005-02-10 | Applied Research Systems Ars Holding N.V. | 2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
EP1790342A1 (de) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
JP2009544723A (ja) * | 2006-07-24 | 2009-12-17 | スミスクライン・ビーチャム・コーポレイション | Pi3キナーゼ阻害剤としてのチオゾリジンジオン誘導体 |
CN102015691B (zh) * | 2008-04-29 | 2014-01-08 | 诺华股份有限公司 | 作为活化素样受体激酶(alk4或alk5)抑制剂的咪唑并吡啶衍生物 |
WO2010030727A1 (en) * | 2008-09-10 | 2010-03-18 | Wyeth Llc | 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
US8609666B2 (en) * | 2009-02-12 | 2013-12-17 | Merck Serono Sa | 2-morpholino-pyrido[3,2-D]pyrimidines |
ES2629170T3 (es) * | 2009-12-04 | 2017-08-07 | Senhwa Biosciences, Inc. | Pirazolopirimidinas y heterociclos relacionados como inhibidores de CK2 |
US8563539B2 (en) | 2009-12-23 | 2013-10-22 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
WO2012145617A2 (en) * | 2011-04-22 | 2012-10-26 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
CA2848877A1 (en) * | 2011-09-15 | 2013-03-21 | Taipei Medical University | Use of indolyl and indolinvl hvdroxamates for treating heart failure or neuronal injury |
WO2013051672A1 (ja) * | 2011-10-04 | 2013-04-11 | 株式会社ヤクルト本社 | チアゾリジン誘導体又はその塩を有効成分とする医薬品 |
KR101990605B1 (ko) | 2011-11-04 | 2019-06-18 | 자스코 파머수티컬스, 엘엘씨 | 아미노피리미딘 키나아제 억제제 |
EP2876109A4 (en) * | 2012-07-23 | 2016-03-16 | Yuhan Corp | FUSHANE-CONTAINING FURANE-CONTAINING COMPOUND OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
EP2916868B1 (en) | 2012-11-08 | 2022-05-11 | Rhizen Pharmaceuticals S.A. | Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor |
KR20240017991A (ko) * | 2015-04-29 | 2024-02-08 | 라포 테라퓨틱스, 인크. | 아자벤즈이미다졸 및 ampa 수용체 조절제로서의 이의 용도 |
JP6804469B2 (ja) | 2015-04-29 | 2020-12-23 | ヤンセン ファーマシューティカ エヌ.ベー. | ベンゾイミダゾロン及びベンゾチアゾロン化合物並びにampa受容体調節因子としてのそれらの使用 |
CN107567452B (zh) | 2015-04-29 | 2020-07-07 | 詹森药业有限公司 | 咪唑并哌嗪和吡唑并嘧啶以及它们作为ampa受体调节剂的用途 |
CN107750250B (zh) | 2015-04-29 | 2021-09-07 | 詹森药业有限公司 | 吲哚酮化合物及其作为ampa受体调节剂的用途 |
WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
CN106588909B (zh) * | 2017-01-06 | 2019-08-27 | 广东工业大学 | 一种喹啉类衍生物的制备及其在抗炎中的应用 |
CN109575435A (zh) | 2017-09-14 | 2019-04-05 | 株式会社日化精密科技 | 聚丙烯树脂组合物、聚丙烯树脂成形体以及聚丙烯树脂成形体的制造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA011807B1 (ru) * | 2002-07-10 | 2009-06-30 | Лаборатуар Сероно Са | Азолидинонвинильные производные конденсированного бензола |
AU2003280188A1 (en) * | 2002-12-06 | 2004-06-30 | Warner-Lambert Company Llc | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
WO2004056820A1 (en) | 2002-12-20 | 2004-07-08 | Warner-Lambert Company Llc | Benzoxazines and derivatives thereof as inhibitors of pi3ks |
US7202363B2 (en) * | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
WO2005011686A1 (en) * | 2003-07-28 | 2005-02-10 | Applied Research Systems Ars Holding N.V. | 2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
CA2570968A1 (en) * | 2004-06-17 | 2006-01-26 | Wyeth | Gonadotropin releasing hormone receptor antagonists |
AU2005293556A1 (en) * | 2004-10-12 | 2006-04-20 | Merck Serono Sa | PI3 Kinase gamma inhibitors for the treatment of anaemia |
US20080306057A1 (en) * | 2005-10-11 | 2008-12-11 | Laboratories Serono Sa | P13K Inhibitors for the Treatment of Endometriosis |
AR059733A1 (es) * | 2006-03-07 | 2008-04-23 | Smithkline Beecham Corp | Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion |
WO2008028141A2 (en) * | 2006-08-31 | 2008-03-06 | Array Biopharma Inc. | Raf inhibitor compounds and methods of use thereof |
WO2009009793A2 (en) * | 2007-07-12 | 2009-01-15 | University Of South Florida | Inhibitors of akt/pkb with anti-tumor activity |
US7932251B2 (en) * | 2007-07-16 | 2011-04-26 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
-
2005
- 2005-09-02 CN CN200580037159XA patent/CN101052640B/zh not_active Expired - Fee Related
- 2005-09-02 KR KR1020077007588A patent/KR101229647B1/ko not_active IP Right Cessation
- 2005-09-02 JP JP2007528883A patent/JP5209311B2/ja not_active Expired - Fee Related
- 2005-09-02 SI SI200531418T patent/SI1786812T1/sl unknown
- 2005-09-02 PL PL05797231T patent/PL1786812T3/pl unknown
- 2005-09-02 MX MX2007002604A patent/MX2007002604A/es active IP Right Grant
- 2005-09-02 ZA ZA200701666A patent/ZA200701666B/en unknown
- 2005-09-02 CA CA2576765A patent/CA2576765C/en not_active Expired - Fee Related
- 2005-09-02 WO PCT/EP2005/054339 patent/WO2006024666A1/en active Application Filing
- 2005-09-02 EP EP05797231A patent/EP1786812B1/en active Active
- 2005-09-02 AT AT05797231T patent/ATE532783T1/de active
- 2005-09-02 EA EA200700541A patent/EA012178B1/ru not_active IP Right Cessation
- 2005-09-02 AU AU2005279156A patent/AU2005279156B2/en not_active Ceased
- 2005-09-02 BR BRPI0515627-0A patent/BRPI0515627A/pt not_active IP Right Cessation
- 2005-09-02 US US11/574,613 patent/US7842698B2/en not_active Expired - Fee Related
-
2007
- 2007-02-19 IL IL181415A patent/IL181415A/en not_active IP Right Cessation
- 2007-03-27 NO NO20071605A patent/NO20071605L/no not_active Application Discontinuation
-
2008
- 2008-01-16 HK HK08100536.3A patent/HK1106773A1/xx not_active IP Right Cessation
-
2010
- 2010-10-18 US US12/906,729 patent/US8058289B2/en not_active Expired - Fee Related
-
2011
- 2011-11-11 HR HR20110834T patent/HRP20110834T1/hr unknown
-
2012
- 2012-02-02 CY CY20121100119T patent/CY1112316T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20110834T1 (hr) | 2011-12-31 |
JP2008511589A (ja) | 2008-04-17 |
WO2006024666A1 (en) | 2006-03-09 |
EP1786812A1 (en) | 2007-05-23 |
SI1786812T1 (sl) | 2011-12-30 |
MX2007002604A (es) | 2007-04-25 |
IL181415A0 (en) | 2007-07-04 |
KR101229647B1 (ko) | 2013-02-05 |
HK1106773A1 (en) | 2008-03-20 |
BRPI0515627A (pt) | 2008-07-29 |
JP5209311B2 (ja) | 2013-06-12 |
US20110034458A1 (en) | 2011-02-10 |
EA200700541A1 (ru) | 2007-08-31 |
CN101052640B (zh) | 2011-05-11 |
PL1786812T3 (pl) | 2012-04-30 |
AU2005279156B2 (en) | 2011-06-02 |
EP1786812B1 (en) | 2011-11-09 |
IL181415A (en) | 2012-09-24 |
CA2576765A1 (en) | 2006-03-09 |
CN101052640A (zh) | 2007-10-10 |
US8058289B2 (en) | 2011-11-15 |
ATE532783T1 (de) | 2011-11-15 |
CA2576765C (en) | 2013-05-28 |
US20080269227A1 (en) | 2008-10-30 |
KR20070053315A (ko) | 2007-05-23 |
EA012178B1 (ru) | 2009-08-28 |
NO20071605L (no) | 2007-05-31 |
US7842698B2 (en) | 2010-11-30 |
AU2005279156A1 (en) | 2006-03-09 |
ZA200701666B (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112316T1 (el) | Πυριδινο μεθυλενο αζολιδινονες και η χρηση αυτων ως αναστολεις φωσφοϊνοσιτιδιων | |
CY1106921T1 (el) | Παραγωγα θειαζολιου και η χρηση αυτων | |
UA100358C2 (xx) | Похідні піразину та їх застосування | |
UA96735C2 (en) | Thiazole derivatives and use thereof | |
UA92489C2 (en) | Thiazole derivatives and use thereof | |
MX2009009031A (es) | Compuestos de quinoxalina y uso de los mismos. | |
RS115904A (en) | Azolidinone-vinyl fused benzene derivatives | |
EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
ATE448232T1 (de) | Substituierte heterozyklen | |
ATE410443T1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
ATE455789T1 (de) | Substituierte nonadepsipeptide | |
UA88314C2 (en) | Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors | |
EA200701877A1 (ru) | Производные замещённых пиридинов |